KMS-21-BMHomo sapiens (Human)Undefined cell line type

Also known as: Kawasaki Medical School-21-Bone Marrow, KMS21BM, KMS-21BM

🤖 AI SummaryBased on 8 publications

Quick Overview

Human multiple myeloma cell line with known genetic alterations and drug resistance profiles.

Detailed Summary

KMS-21-BM is a human multiple myeloma cell line derived from a patient with plasma cell leukemia. It is characterized by specific genetic alterations, including amplification of the PDZK1 gene, which has been associated with drug resistance in multiple myeloma. This cell line is frequently used in research to study the molecular mechanisms of drug resistance and to evaluate the efficacy of novel therapeutic agents. The cell line has been involved in studies related to the 1q12-q22 amplicon, which is linked to poor prognosis and resistance to chemotherapy. KMS-21-BM is also part of a comprehensive database of cancer cell lines, providing valuable insights into the genetic and transcriptomic profiles of multiple myeloma. Its use in research has contributed to understanding the complexities of tumor biology and the development of targeted therapies.

Research Applications

Study of drug resistance mechanismsEvaluation of novel therapeutic agentsAnalysis of genetic alterations in multiple myelomaInvestigation of 1q12-q22 amplicon effectsTranscriptomic and genomic profiling

Key Characteristics

Amplification of PDZK1 geneResistance to chemotherapeutic agentsPart of comprehensive cancer cell line databasesUsed in studies of multiple myeloma biology
Generated on 6/19/2025

Basic Information

Database IDCVCL_2991
SpeciesHomo sapiens (Human)

Donor Information

Age62
Age CategoryAdult
SexMale
Raceasian

Disease Information

DiseaseMature B-Cell Neoplasms
LineageLymphoid
SubtypePlasma Cell Myeloma
OncoTree CodePCM

DepMap Information

Source TypeHSRRB
Source IDACH-000598_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNRASp.Gln61Leu (c.182A>T)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12,13
D13S317
8,14
D16S539
9
D18S51
13
D21S11
31,32.2
D3S1358
15,17
D5S818
10,11
D7S820
8,13
D8S1179
12
FGA
19,22,23
Penta D
9,10
Penta E
11,12
TH01
7,9
TPOX
8
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis.

Sirota M., Wiita A.P.

Leukemia 34:2754-2765(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Check your cultures! A list of cross-contaminated or misidentified cell lines.

Freshney R.I.

Int. J. Cancer 127:1-8(2010).

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Taniwaki M., Inazawa J.

Am. J. Pathol. 165:71-81(2004).

False leukemia-lymphoma cell lines: an update on over 500 cell lines.

Drexler H.G., Dirks W.G., Matsuo Y., MacLeod R.A.F.

Leukemia 17:416-426(2003).

Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).

Yamada O.

Leuk. Lymphoma 42:761-774(2001).